Aelius Biotech Limited
Company 11535653 Active
Connected board network
The connection graph needs a free account.
This company's record is public. The network of who else its directors govern is compiled from the registers by us, and an account keeps it out of bulk scrapers.
Sign in, freeBoard DNA
How this board is put together, from the Companies House officer record and Charity Commission trustee records - deterministic, no AI.iBoard compositionCounted from the dated Companies House officer record: the current directors only, past directors excluded.
4 directors on the board
- Weaver, Richard, Dr Director · appointed 2023
- Wilcox, Matthew David, Dr Director · appointed 2022
- Jeffrey Peter Pearson Director · appointed 2019
- Chater, Peter Ian, Dr Director · appointed 2019
Directors past 6 years
- Jeffrey Peter Pearson Director · appointed 2019
- Chater, Peter Ian, Dr Director · appointed 2019
First-time vs portfolio directors
First-time (3)
- Wilcox, Matthew David, Dr Director · appointed 2022
- Jeffrey Peter Pearson Director · appointed 2019
- Chater, Peter Ian, Dr Director · appointed 2019
Portfolio (1)
- Weaver, Richard, Dr Director · appointed 2023
Left in the last 12 months
- Raymond, Alan Michael, Dr Director · appointed 2023 · resigned 2025
Where else this board sits iWhere else this board sitsThe charitable fields these directors govern in elsewhere, by Charity Commission classification. Excludes this company and any charity it is the legal face of.
The sectors these directors govern in elsewhere. This company, and any charity it is the legal face of, are excluded - counting them would just tell you what you are already looking at.
Gaps to watch
- Several long-serving directors could step down together
- Narrow spread of sectors across the board
Where to look Suggested search: succession planning for long-tenured seats; directors from a wider range of sectors.
Related organisations iRelated organisationsTwo groups, both deterministic from public records. Related organisations share two or more directors with this board - a real structural link, such as a subsidiary or group company. Connected through a shared director share exactly one person - a genuine connection, but not the same group.
Connected through a shared director
- Immuone LTD 1 shared director
- Drug Discovery Solutions Limited 1 shared director
- Forge Genetics LTD 1 shared director
Deterministic, from public records.
Company details
| Number | 11535653 |
| Status | Active |
| Type | Private Limited Company |
| Incorporated | 24/08/2018 |
| Address | BLANDFORD STUDIOS, 12 BLANDFORD SQUARE, NEWCASTLE UPON TYNE, NE1 4HZ |
| Accounts next due | 30/09/2027 |
| Accounts last made up | 31/12/2025 |
Industry (SIC)
Owned by (2) iOwned byIndividuals and companies registered as having significant control over this company, from the Companies House PSC (persons with significant control) register. People whose ownership could not be confirmed to one individual are not listed as confirmed owners.
- Harvey Justin Dettmar ceased 2019-05-08
75-100% shares, 75-100% voting, appoints directors · notified 2018-08-24 - Newcastle University Holdings Limited ceased 2023-11-14
25-50% shares, 25-50% voting · notified 2019-08-13
Officers (8)
- Weaver, Richard, Dr Director · appointed 2023
- Wilcox, Matthew David, Dr Director · appointed 2022
- Jeffrey Peter Pearson Director · appointed 2019
- Chater, Peter Ian, Dr Director · appointed 2019
Show 4 former officers
- Raymond, Alan Michael, Dr Director · appointed 2023 · resigned 2025
- Geoffrey Charles Peter Maclauchlan Secretary · appointed 2023 · resigned 2025
- Dettmar, Peter William, Professor Director · appointed 2019 · resigned 2021
- Harvey Justin Dettmar Director · appointed 2018 · resigned 2019
Directors and officers on the Companies House record, current and former.
Report an error in this record - let us know.
Related record